Back
Open Access

Dosimetric Predictors of New-Onset Atrial Fibrillation Following Thoracic Radiotherapy for Lung Cancer

Session: Prevalence and incidence of atrial fibrillation
Topic: Prevalence and Incidence of Atrial Fibrillation
Speaker: Doctor H. Yalman (Istanbul, TR)
Event: EHRA 2026

Congress Presentation

Add to my library

Like

About the speaker

Doctor Hakan Yalman

Istanbul University Cerrahpasa Faculty of Medicine, Istanbul (Turkiye)
1 presentation
0 follower

5 more presentations in this session

CHADSVASc score as a predictor of atrial fibrillation after cryptogenic stroke: implications for early anticoagulation

Speaker: Doctor B. Brescia (Napoly, IT)

Access
Abstract
Like
Thumbnail

Beyond atrial fibrillation screening: characterizing other clinically relevant arrhythmias detected during 14-day electrocardiogram monitoring.

Speaker: Doctor E. Rakai (Stockholm, SE)

Access
Abstract
Like
Thumbnail

Biomarkers in atrial fibrillation: insights from the ACaSA study

Speaker: Doctor V. Bilgeri (Innsbruck, AT)

Access
Abstract
Like
Thumbnail

Supine hypertension as a predictor of atrial fibrillation: a UK biobank cohort study

Speaker: Assistant Professor K. Lee (Seoul, KR)

Access
Abstract
Like
Thumbnail

Atrial fibrillation reporting with semaglutide versus tirzepatide in eudravigilance: a comparative disproportionality analysis

Speaker: Doctor Y. Shhab (Bucharest, RO)

Access
Abstract
Like
Thumbnail

Access the full session

Prevalence and incidence of atrial fibrillation

Speakers: Doctor H. Yalman, Doctor B. Brescia, Doctor E. Rakai, Doctor V. Bilgeri, Assistant Professor K. Lee...
Access
Like
Thumbnail

About the event

Image

EHRA 2026

12 April - 14 April 2026

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

novartis Explore sponsored resources
novartis Explore sponsored resources